Food And Drug Administration Releases An Effortless Restriction On Abortion Pills

Some women choose to resolve their unwanted pregnancy at home by taking abortion pills. Earlier this week FDA releases news about a drug called mifepristone, which has two intakes instead of three. 

Recent news from WebMD says the FDA recently released an information that they have lessened the dosage of the drug from 600 mg to 200mg. Lessening the dosage is also to reduce the occurence of side effects to the person who intakes the drug.

"Unlike state and federal anti-choice laws that restrict a woman's access to an abortion, the FDA decision to make mifepristone available to more women in this country is based on science that shows this usage is safe and medically sound," Llyse Hogue, president of NARAL Pro-Choice America, said. "It is high time to put medicine back into the hands of medical professionals and take it out of politicians' hands."

Some groups who are against abortion have taken the news in a different perspective. Physicians said that the original abortion medication contradicts some medical practices and the labels were outdated.

A staff attorney for Americans United for Life said, "The new label affirms the deadly realities of chemical abortion and underscores the need for in-person patient examination and follow-up care as well as the fact that the abortion drug regimen presents serious risks to women's health."

According to Chicago Business, FDA informed the manufacturer of the drug last Tuesday that the drug is safe to use and it is effective for stopping the pregnancy in accordance with the new label. The mifepristone or also called the abortion pill is manufactured by Danco Laboratories and used in combination with misoprostol to stop a pregnancy.